Dual-ligand drug-loaded nanoparticles

Lysosomal escape boosts efficacy

Co-loaded with an angiogenesis inhibitor and a STING agonist, these nanoparticles trigger lysosomal escape for synergistic anti-tumor immunity, offering a novel strategy against peritoneal metastatic colorectal cancer.

Meng, Wang · Yutong, Qian · Li, Yicong · XiCheng, Li · Mei, Zhu · Hu, Danrong · Ran, Li · Pan, Meng · Yang, Yun · Jianan, Li · Qian, Zhiyong

Acta Pharmaceutica Sinica B 2026

Advantages

Significantly inhibit tumor proliferation

Normalize pathological vasculature

Reprogram the immunosuppressive microenvironment

Reduce tumor burden and ascites